Fund Overview of Bandhan Healthcare Fund Regular - Growth
-
₹9.82NAV
-
EquityFund Category
Asset Allocation
equities
73.81%debt instruments
0.24%other assets or cash equivalents
25.95%Bandhan Healthcare Fund Regular - Growth is one Equity mutual fund offered by Bandhan Mutual Fund. Launched on 28 Nov 2025, the fund aims To create wealth over a long term. Investment predominantly in equity and equity related instruments of pharma, healthcare and allied companies. The portfolio allocation consists of 73.81% in equities, 0.24% in debt instruments, 25.95% in other assets or cash equivalents. it has delivered a return of 0.00% in the last year, a total return since inception of -1.84%. About Bandhan Healthcare Fund Regular - Growth
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -1.22% | -1.31% | 3.30% | 27.78% | 19.12% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -1.27% | -1.52% | 2.48% | 26.70% | 18.07% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -1.89% | -2.09% | -0.38% | 21.93% | 15.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -1.99% | -2.43% | -1.67% | 20.31% | 13.92% |
More funds from Bandhan Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Bandhan Bse Healthcare Index Fund Regular-growth
|
₹19 | -1.70% | -2.51% | -0.26% | -1.94% | - |
|
Bandhan Bse Healthcare Index Fund Direct-growth
|
₹19 | -1.64% | -2.31% | 0.14% | -1.15% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹39.63 | 26.70% | 18.07% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹42.83 | 27.78% | 19.12% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹33.70 | 21.93% | 15.55% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹30.54 | 20.31% | 13.92% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹149.10 | 21.93% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹14.95 | 22.10% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Reverse Repo | Unspecified | 41.62% | ₹121.36 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.05% | ₹29.31 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.55% | ₹22.01 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.48% | ₹18.88 Cr |
| Cipla Ltd | Healthcare | 6.30% | ₹18.38 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.18% | ₹18.02 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.55% | ₹16.19 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.25% | ₹12.40 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.85% | ₹8.32 Cr |
| Syngene International Ltd | Healthcare | 2.78% | ₹8.10 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.00% | ₹5.84 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.94% | ₹5.66 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.93% | ₹5.63 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.85% | ₹5.41 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.83% | ₹5.34 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.82% | ₹5.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.76% | ₹5.14 Cr |
| Pfizer Ltd | Healthcare | 1.71% | ₹4.98 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.41% | ₹4.11 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.26% | ₹3.68 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.14% | ₹3.33 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.05% | ₹3.06 Cr |
| Abbott India Ltd | Healthcare | 1.03% | ₹3.01 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.60% | ₹1.74 Cr |
| Concord Biotech Ltd. | Healthcare | 0.49% | ₹1.42 Cr |
| Others Mrgn Money | Unspecified | 0.24% | ₹0.69 Cr |
| Net Payables | Unspecified | -15.67% | ₹-45.71 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹42.83 | 27.78% | 19.12% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹39.63 | 26.70% | 18.07% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹33.70 | 21.93% | 15.55% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹30.54 | 20.31% | 13.92% | - |
Bandhan Healthcare Fund Regular - Growth
What is the portfolio composition of Bandhan Healthcare Fund Regular - Growth?
Equity: 73.81%, Debt: 0.24%, Others: 25.95%.
What is the market-cap allocation of Bandhan Healthcare Fund Regular - Growth?
Large Cap: 59.67%, Mid Cap: 12.06%, Small Cap: 28.28%.
Which are the top companies Bandhan Healthcare Fund Regular - Growth has invested in?
- Reverse Repo – 41.62% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.05% of the fund's portfolio
- Apollo Hospitals Enterprise Ltd – 7.55% of the fund's portfolio
- Dr. Reddy's Laboratories Ltd – 6.48% of the fund's portfolio
- Cipla Ltd – 6.30% of the fund's portfolio
Which are the major sectors Bandhan Healthcare Fund Regular - Growth focuses on?
- Healthcare – 73.81% of the fund's portfolio
- Unspecified – 26.19% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


